Recombinant IL-3 induces histamine release from human basophils

Area of Science:

• Immunology
• Allergy Research
• Cellular Signaling

Background:

• Human basophils play a key role in allergic responses by releasing histamine.
• Interleukin-3 (IL-3) is a cytokine known to influence immune cell activity.
• Atopic individuals exhibit heightened responses to certain immune stimuli.

Purpose of the Study:

• To investigate the effect of human recombinant interleukin-3 (rIL-3) on histamine release from human basophils.
• To elucidate the mechanism by which IL-3 induces histamine release and its relationship with IgE.
• To determine the potential pro-inflammatory role of IL-3 in allergic reactions.

Main Methods:

• Human basophils from atopic and non-atopic donors were isolated and treated with varying concentrations of rIL-3.
• Histamine release assays were performed to quantify the response.
• Experiments involving removal and passive sensitization of surface IgE were conducted to assess IgE's role.
• Comparison of IL-3-induced release with anti-IgE stimulation was performed.

Main Results:

• Human rIL-3 induced histamine release from a subset of human basophils, with a more pronounced response observed in cells from atopic donors.
• The dose-response curves for IL-3 were highly variable.
• IL-3-induced histamine release was slower and required more calcium compared to anti-IgE.
• Basophils depleted of surface IgE became unresponsive to IL-3, but responsiveness was restored by passive sensitization with specific IgE.
• IL-3 does not directly interact with IgE but rather potentiates the response when basophils are passively sensitized with IgE or stimulated with secretagogues.

Conclusions:

• Human rIL-3 induces histamine release from basophils in an IgE-dependent manner, highlighting IgE heterogeneity.
• IL-3 appears to potentiate the effects of IgE or other secretagogues, suggesting a pro-inflammatory role in allergic conditions.